Literature DB >> 21376736

Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors.

David L Myer1, Susan B Robbins, Moying Yin, Gregory P Boivin, Yang Liu, Kenneth D Greis, El Mustapha Bahassi, Peter J Stambrook.   

Abstract

The polo-like kinases (Plks1-5) are emerging as an important class of proteins involved in many facets of cell cycle regulation and response to DNA damage and stress. Here we show that Plk3 phosphorylates the key cell cycle protein phosphatase Cdc25A on two serine residues in its cyclinB/cdk1 docking domain and regulates its stability in response to DNA damage. We generated a Plk3 knock-out mouse and show that Cdc25A protein from Plk3-deficient cells is less susceptible to DNA damage-mediated degradation than cells with functional Plk3. We also show that absence of Plk3 correlates with loss of the G1/S cell cycle checkpoint. However, neither this compromised DNA damage checkpoint nor reduced susceptibility to proteasome-mediated degradation after DNA damage translated into a significant increase in tumor incidence in the Plk3-deficient mice.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376736     DOI: 10.1016/j.mrfmmm.2011.02.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

Review 1.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

2.  The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies.

Authors:  Mahamat Babagana; Julia V Kichina; Hannah Slabodkin; Sydney Johnson; Alexei Maslov; Lorin Brown; Kristopher Attwood; Mikhail A Nikiforov; Eugene S Kandel
Journal:  Mol Carcinog       Date:  2019-09-30       Impact factor: 4.784

Review 3.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 4.  Polo-like kinase 3, hypoxic responses, and tumorigenesis.

Authors:  Dazhong Xu; Wei Dai; Cen Li
Journal:  Cell Cycle       Date:  2017-09-21       Impact factor: 4.534

5.  Cytoskeletal architecture and cell motility remain unperturbed in mouse embryonic fibroblasts from Plk3 knockout mice.

Authors:  Daniel R Michel; Kyu-Shik Mun; Chia-Chi Ho; Peter J Stambrook
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-02

6.  Polo-like kinase is required for synaptonemal complex disassembly and phosphorylation in mouse spermatocytes.

Authors:  Philip W Jordan; Jesse Karppinen; Mary A Handel
Journal:  J Cell Sci       Date:  2012-08-01       Impact factor: 5.285

7.  CRL Ubiquitin Ligases and DNA Damage Response.

Authors:  Ju-Mei Li; Jianping Jin
Journal:  Front Oncol       Date:  2012-04-09       Impact factor: 6.244

8.  Nuclear receptor LRH-1/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution.

Authors:  Jennifer L Mamrosh; Jae Man Lee; Martin Wagner; Peter J Stambrook; Richard J Whitby; Richard N Sifers; San-Pin Wu; Ming-Jer Tsai; Francesco J Demayo; David D Moore
Journal:  Elife       Date:  2014-04-15       Impact factor: 8.140

9.  Polo-Like Kinase 3 Appears Dispensable for Normal Retinal Development Despite Robust Embryonic Expression.

Authors:  Jillian J Goetz; Lauren A Laboissonniere; Andrea K Wester; Madison R Lynch; Jeffrey M Trimarchi
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

Review 10.  Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity.

Authors:  Thomas Kietzmann; Daniela Mennerich; Elitsa Y Dimova
Journal:  Front Cell Dev Biol       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.